United States · Bill · HR
H.R. 3925 (105th)
Prescription Drug Price Monitoring Commission Act of 1998
Introduced
21 May 1998
Last action
—
Status
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Prescription Drug Price Monitoring Commission Act of 1998 - Establishes the Prescription Drug Price Monitoring Commission which shall conduct specified studies concerning U.S. pharmaceutical prices, including the establishment of a pharmaceutical products price review board. Terminates the Commission on a specified date. Directs the Secretary of Health and Human Services to study and report on Federal subsidies and incentives provided to the pharmaceutical industry. Amends title XIX (Medicaid) of the Social Security Act to require drug manufacturers participating in the Medicaid rebate program to report within a certain time after the end of each calendar year (currently, after each rebate period) on the average price at which the manufacturer sold each covered outpatient drug in Canada, Australia, Mexico, and the European Union countries.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 May 1998
Introduced in House (PDF)
Introduced in House · EN · 21 May 1998
Introduced in House
summary · EN · 21 May 1998
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/105th-congress/house-bill/3925
- Open data entity: https://api.congress.gov/v3/bill/105/hr/3925